AMB-01™ – JC BioSciences has formed Advanced Microbiome Labs, LLC, a joint venture with Technology Commercialization Corp. and acquired the patent rights and worldwide distributions rights to AMB-01™, a post-biotic supplement and food product developed at the Pavlov Institute in St. Petersburg Russia. Although a dietary supplement, JC Bioscience plans to research the product’s antibacterial, antiviral and immunomodulatory properties with in vitro and in vivo tests and human clinical trials. Product development is underway the market the product over-the-counter in a number of forms.
JC BioSciences has several human supplement products in concept development stage. One focus is enhanced delivery technology for popular supplements for which there is compelling anti-aging clinical evidence and an already proven market.